Fda authorizes new high-throughput, automated system for leading covid-19 test

Waltham, mass., april 12, 2021 /prnewswire/ -- thermo fisher scientific inc. (nyse:tmo), the world leader in serving science, today announced that the u.s. food and drug administration (fda) has granted emergency use authorization (eua) for the thermo fisher scientific amplitude solution with the taqpath covid-19 high-throughput combo kit.
TMO Ratings Summary
TMO Quant Ranking